0 NASDAQ Companies - August 12, 2020TELA Bio Announces Second Quarter 2020 Financial ResultsMALVERN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company […]Read More
0 NASDAQ Companies - August 12, 2020Lyft Announces Second Quarter ResultsResults reflect strong cost management and execution in challenging environmentEnded quarter with $2.8 billion of unrestricted cash, cash equivalents and […]Read More
0 NASDAQ Companies - August 12, 2020SmileDirectClub Reports Second Quarter 2020 Financial ResultsNASHVILLE, Tenn., Aug. 12, 2020 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC) today announced its financial results for the second […]Read More
0 NASDAQ Companies - August 12, 2020One Medical Announces Results for Second Quarter 2020Second Quarter 2020 Ending Membership Count of 475,000, a 25% Increase Year-Over-YearSecond Quarter 2020 Net Revenue of $78.0 Million, an […]Read More
0 NASDAQ Companies - August 12, 2020Exela Technologies, Inc. to Host Fireside Chat at the Credit Suisse 3rd Annual FinTech ConferenceIRVING, Texas, Aug. 12, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a location-agnostic global […]Read More
0 TSX News - August 12, 2020Altus Group Reports Second Quarter 2020 Financial ResultsTORONTO, Aug. 12, 2020 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Groupʺ or “the Company”) (TSX: AIF), a leading provider […]Read More
0 NYSE Companies - August 12, 2020Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy in AustraliaMINNEAPOLIS, Aug. 12, 2020 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on […]Read More
0 TSX News - August 12, 2020Points International Reports Second Quarter 2020 Results– Achieves Positive Adjusted EBITDA for the Quarter –– Total Funds Available Remains at Approximately $107 Million –TORONTO, Aug. 12, […]Read More
0 NASDAQ Companies - August 12, 2020Brickell Biotech Reports Second Quarter 2020 Financial Results and Provides Corporate UpdatePositive data from the Sofpironium Bromide Phase 3 pivotal study in Japan presented in Q2 2020 by development partner, KakenBOULDER, […]Read More
0 NASDAQ Companies - August 12, 2020Neoleukin Therapeutics Announces Second Quarter 2020 Financial Results & Provides Corporate UpdateNL-201 IND submission anticipated during fourth quarter of 2020Recent financing raises $71.4M in net proceeds to enable broad NL-201 clinical […]Read More